Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
lunes, octubre 26
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Ardelyx Inc
ARDX
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$3.08
-0.12
-3.75%
Últ. Act.: Oct 23, 7:58 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Ganancias:
Beneficios de Q3 2026 dentro de 9 días de ahora en mar nov 3rd, después del cierre del mercado
Ardelyx Financials
Ardelyx (ARDX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Ardelyx Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $118.100M Miss $121.601M Estimate
Ardelyx (NASDAQ:ARDX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is a 12.5 percent increase over losses of $(0.08) per share from the same
Benzinga Newsdesk
PRO
Ardelyx Q1 EPS $(0.15) Misses $(0.13) Estimate, Sales $94.473M Beat $92.655M Estimate
Ardelyx (NASDAQ:ARDX) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 11.76 percent increase over losses of $(0.17) per share from the
Benzinga Newsdesk
Earnings Scheduled For April 30, 2026
Benzinga Insights
Ardelyx Lead Drug Growth Fails To Lift Sentiment, Stock Drops
Ardelyx stock drops premarket despite revenue beat as investors weigh IBSRELA growth outlook and mixed technical signals heading into 2026.
Vandana Singh
Ardelyx Q4 Earnings Report: What Investors Need to Know
Benzinga Insights
PRO
Ardelyx Q4 EPS $0.00 Misses $0.01 Estimate, Sales $125.215M Beat $118.134M Estimate
Ardelyx (NASDAQ:ARDX) reported quarterly earnings of $0.00 per share which missed the analyst consensus estimate of $0.01 by 85.71 percent. This is a 95 percent decrease over earnings of $0.02 per share from the same
Benzinga Newsdesk
